There are several global listed companies involved in the production of GLP-1 drugs, and other healthcare companies that may be beneficiaries of this innovation
Participants were randomly assigned to one of five therapies: exenatide alone, dapagliflozin alone, dual therapy of exenatide and dapagliflozin, combined dapagliflozin and metformin therapy, or the weight-loss medication phentermine/topiramate extended-release
In certain conditions, vitamin b12 drops to such low levels which can cause different diseases in your cats body and reason is impaired absorption of cobalamin
Self-reported community timelines describe headache and (less commonly) chest pressure within 1-4 hours of higher doses
If solid food intake is low on a given day due to nausea or appetite suppression, a protein supplement can bridge the gap without requiring a full meal
Pipeline of obesity pharmacotherapies GLP-1 receptor agonists GLP-1 RA increase satiety, reduce food intake and delay gastric emptying whilst they also stimulate insulin release and inhibit glucagon secretion in a glucose-dependent manner (Fig
.png)
